FDA

Latest News


Latest Videos


Shorts

Pharmaceutical Executive
0:41
The Impact of FDA's Approval of Papzimeos
a year ago
by
Nicholas Jacobus(+1 more)
Ryan Conrad
0:57
FDA's Priority Voucher Review Program's Impact on Timelines
a year ago
by
Mike Hollan(+1 more)

More News

Pharmaceutical Executive Daily

FDA reportedly shelves its Commissioner’s National Priority Voucher program, Eli Lilly breaks ground on a $3.5 billion Pennsylvania manufacturing site for next-generation obesity treatments, and Parexel’s Stacy Hurt on how small protocol decisions can become enrollment and retention barriers.

Pharmaceutical Executive Daily

FDA approves Merck KGaA’s Pimjetmi for tenosynovial giant cell tumor, Parexel’s Stacy Hurt on when patient input should enter the clinical research process, and Ignite Proteomics’ Dr. Brian Corgiat on adjusting for tumor mutations in treatment decisions.

Pharmaceutical Executive daily

FDA grants accelerated approval to INOVIO’s Voceryq to reduce surgical burden in recurrent respiratory papillomatosis, Brox.AI’s Hamish Brocklebank on the three levels of digital clone use cases in pharma, and CytoDyn’s Dr. Jay Lalezari on his path from HIV clinician to CEO.